Idiopathic CD4+ T-lymphocytopenia--an analysis of five patients with unexplained opportunistic infections. 1993

T J Spira, and B M Jones, and J K Nicholson, and R B Lal, and T Rowe, and A C Mawle, and C B Lauter, and J A Shulman, and R A Monson
Immunology Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333.

BACKGROUND Although patients with idiopathic CD4+ T-lymphocytopenia and serious opportunistic infections have been described previously, the clinical and immunologic features of this condition have not been well defined. METHODS We studied in detail five patients with idiopathic CD4+ T-lymphocytopenia. The studies included serologic testing, culture, and polymerase chain reaction for the human immunodeficiency virus (HIV) types 1 and 2, serologic testing for the human T-cell lymphotropic virus (HTLV) types I and II, lymphocyte phenotyping, immunoglobulin quantitation, and lymphocyte-transformation assays, as well as attempts to isolate a retroviral agent. The results were compared with those in HIV-infected persons matched for CD4+ T-cell counts and with those in normal controls. We also studied the spouses of patients and the blood donors for one patient. RESULTS In these five patients, there was no evidence of either HIV or HTLV infection. All the patients had both low percentages and low counts of CD4+ T cells, with relative increases in percentages, but not counts, of CD8+ cells. Numbers of B cells and natural killer cells were generally normal. As compared with HIV-infected persons, our patients had lower percentages and counts of CD8+ cells and more lymphopenia. CD4+ counts were relatively stable over time. Instead of the high immunoglobulin levels seen in HIV infection, these patients had normal or slightly low levels of immunoglobulins. The lymphocyte-transformation response to mitogens and antigens was depressed. Results in spouses and blood donors were normal. CONCLUSIONS Idiopathic CD4+ T-lymphocytopenia differs from HIV infection in its immunologic characteristics and in its apparent lack of progression over time. Nothing about the immunologic or viral-culture studies performed in these patients or about their family members or blood donors suggests that a transmissible agent causes this condition.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008231 Lymphopenia Reduction in the number of lymphocytes. Lymphocytopenia,Lymphocytopenias,Lymphopenias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection
D005260 Female Females

Related Publications

T J Spira, and B M Jones, and J K Nicholson, and R B Lal, and T Rowe, and A C Mawle, and C B Lauter, and J A Shulman, and R A Monson
February 1993, The New England journal of medicine,
T J Spira, and B M Jones, and J K Nicholson, and R B Lal, and T Rowe, and A C Mawle, and C B Lauter, and J A Shulman, and R A Monson
February 1993, The New England journal of medicine,
T J Spira, and B M Jones, and J K Nicholson, and R B Lal, and T Rowe, and A C Mawle, and C B Lauter, and J A Shulman, and R A Monson
December 2008, FEMS immunology and medical microbiology,
T J Spira, and B M Jones, and J K Nicholson, and R B Lal, and T Rowe, and A C Mawle, and C B Lauter, and J A Shulman, and R A Monson
August 1995, Journal of internal medicine,
T J Spira, and B M Jones, and J K Nicholson, and R B Lal, and T Rowe, and A C Mawle, and C B Lauter, and J A Shulman, and R A Monson
April 2013, Avicenna journal of medicine,
T J Spira, and B M Jones, and J K Nicholson, and R B Lal, and T Rowe, and A C Mawle, and C B Lauter, and J A Shulman, and R A Monson
February 1997, Nederlands tijdschrift voor geneeskunde,
T J Spira, and B M Jones, and J K Nicholson, and R B Lal, and T Rowe, and A C Mawle, and C B Lauter, and J A Shulman, and R A Monson
November 1997, Internal medicine (Tokyo, Japan),
T J Spira, and B M Jones, and J K Nicholson, and R B Lal, and T Rowe, and A C Mawle, and C B Lauter, and J A Shulman, and R A Monson
September 1993, The New England journal of medicine,
T J Spira, and B M Jones, and J K Nicholson, and R B Lal, and T Rowe, and A C Mawle, and C B Lauter, and J A Shulman, and R A Monson
January 1998, Ryoikibetsu shokogun shirizu,
T J Spira, and B M Jones, and J K Nicholson, and R B Lal, and T Rowe, and A C Mawle, and C B Lauter, and J A Shulman, and R A Monson
August 1993, The Pediatric infectious disease journal,
Copied contents to your clipboard!